Ascorbic Acid and the Behavioral Response to Haloperidol: Implications for the Action of Antipsychotic Drugs
- 25 January 1985
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 227 (4685) , 438-440
- https://doi.org/10.1126/science.4038426
Abstract
Haloperidol, a widely used antipsychotic drug, was tested for its ability to block the behavioral response to amphetamine and to elicit catalepsy in rats treated with saline or ascorbic acid (1000 milligrams per kilogram of body weight). By itself, ascorbic acid failed to exert significant behavioral effects, but it enhanced the antiamphetamine and cataleptogenic effects of haloperidol (0.1 or 0.5 milligrams per kilogram). These results, combined with a growing body of biochemical evidence, suggest that ascorbic acid plays an important role in modulating the behavioral effects of haloperidol and related antipsychotic drugs.This publication has 23 references indexed in Scilit:
- Critical issues in assessing the behavioral effects of amphetamineNeuroscience & Biobehavioral Reviews, 1984
- Ascorbic acid could be hazardous to your experiments: A commentary on dopamine receptor binding studies with speculation on a role for ascorbic acid in neuronal functionNeuropharmacology, 1983
- The Classification of Dopamine Receptors: Relationship to Radioligand BindingAnnual Review of Neuroscience, 1983
- Ascorbic acid enables reversible dopamine receptor 3H-agonist bindingLife Sciences, 1981
- Adverse Effects of Antipsychotic AgentsDrugs, 1981
- Neostriatal and mesolimbic neurons: Dose-dependent effects of clozapineNeuropharmacology, 1980
- Extrapyramidal side-effectsPharmacology & Therapeutics, 1979
- Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholaminesLife Sciences, 1979
- Symposium on: Receptors of dopamine antagonists: New biochemical approachesLife Sciences, 1978
- Antipsychotic DrugsDrugs, 1977